Phathom Pharmaceuticals, Inc.
PHAT
$11.03
$0.6456.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 38.51% | -3.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 38.51% | -3.86% | |||
| Cost of Revenue | 35.28% | -2.39% | |||
| Gross Profit | 39.00% | -4.08% | |||
| SG&A Expenses | -9.70% | 23.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.41% | 20.54% | |||
| Operating Income | 24.02% | -32.73% | |||
| Income Before Tax | 19.62% | -26.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.62% | -26.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.62% | -26.68% | |||
| EBIT | 24.02% | -32.73% | |||
| EBITDA | 24.06% | -32.86% | |||
| EPS Basic | 20.18% | -25.06% | |||
| Normalized Basic EPS | 20.18% | -25.05% | |||
| EPS Diluted | 20.18% | -25.06% | |||
| Normalized Diluted EPS | 20.18% | -25.05% | |||
| Average Basic Shares Outstanding | 0.69% | 1.30% | |||
| Average Diluted Shares Outstanding | 0.69% | 1.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||